Abstract | BACKGROUND: Recent studies have been explained the role of lipoxygenases (LOX) in the origin of cancer. Among the lipoxygenases, the 5-LOX, 12-LOX and 15-LOX are more important in the cause of neoplastic disorders. In the present investigation, a new series of anticancer agents with 1,3,4-thiadiazole and phthalimide substructures were synthesized and their in vitro cytotoxicity was evaluated by MTT assay. Moreover, enzyme inhibitory potency was also assessed by enzymatic protocol towards 15-LOX-1. Molecular docking was performed to explore in silico binding mode of the target compounds. RESULTS: Tested compounds showed a better cytotoxic activity against HT29 cell line ( colorectal cancer) in comparison with other cell lines (PC3: prostate carcinoma; SKNMC: neuroblastoma). Unfortunately, all of the tested derivatives rendered lower inhibitory potency than quercetin towards 15-LOX-1. Four hydrogen bonds were detected in docking studies for compound 4d as the most potent derivative in enzymatic assay. CONCLUSIONS: The biological results of reported compounds in this research were not so satisfactory. But, further structural modifications are necessary to improve the bioactivity of these derivatives.
|
Authors | Alireza Aliabadi, Ahmad Mohammadi-Farani, Zeinab Hosseinzadeh, Hamid Nadri, Alireza Moradi, Farahnaz Ahmadi |
Journal | Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences
(Daru)
Vol. 23
Pg. 36
(Jul 22 2015)
ISSN: 2008-2231 [Electronic] Switzerland |
PMID | 26197788
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Lipoxygenase Inhibitors
- Phthalimides
- ALOX15 protein, human
- Arachidonate 15-Lipoxygenase
|
Topics |
- Arachidonate 15-Lipoxygenase
(metabolism)
- Cell Line, Tumor
- Cell Survival
(drug effects)
- Humans
- Lipoxygenase Inhibitors
(chemical synthesis, pharmacology)
- Models, Molecular
- Molecular Docking Simulation
- Phthalimides
(chemical synthesis, pharmacology)
- Structure-Activity Relationship
|